VTCN1 and neoplasm: In conclusion, the unique expression of B7H4 in tumor cells and its inverse relationship with the number of tumor-infiltrating CD8 T lymphocytes in breast invasive ductal cancer tissues supports the inhibitory role of tumor surface B7H4 on T cell immune responses.